eLearningClasses.com

Oncologica, a Leading CRO, Selects Arkivum for Integrated Long-Term Data Management of Next-Generation Sequencing Data

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Oncologica, a leading precision oncology profiling company and Contract Research Organization (CRO), has chosen Arkivum to provide an integrated long-term data management solution for regulated genomics and patient data. Data is generated by Thermo Fishers Ion GeneStudio S5 next-generation sequencing (NGS) system.

Oncologica develops precision oncology solutions to personalize cancer treatments. They achieve this by identifying individual genetic biomarkers, and matching individual patient tumours to specific medicines. Oncologica uses the Ion GeneStudio S5 system to run tests and record genomic sequence data.

Dr Marco Loddo, Co-Founder and Scientific Director, Oncologica says: As a CRO, we need to demonstrate stringent data management and safeguarding practices to existing and prospective clients. Thanks to Arkivum and Thermo Fisher, our team can focus on core pharmaceutical activities, knowing that data is secure, usable, shareable, and compliant throughout its lifecycle. Arkivum provides our sponsoring organizations with the data they need, in neat, structured packages, helping us demonstrate value as a professional, long-term CRO partner.

Arkivum is providing an integrated solution that meets data requirements of Thermo Fishers Ion GeneStudio S5 system users such as Oncologica. A secure transfer mechanism migrates sequencing data into the Arkivum platform, where data is safeguarded, indexed, preserved, and made usable according to Oncologicas data policies.

Arkivum Trust makes Oncologicas regulated data discoverable and accessible whenever needed. Ion GeneStudio S5 users are able to search for data managed by Arkivum, share it securely, and re-import for further analysis and experimentation.

As an expanding CRO Oncologica needs to comply with a diverse range of regulatory bodies. Oncologica was satisfied that Arkivums international client base meant they are able to manage sensitive data in compliance with world-wide standards and regulatory bodies, such as MHRA GxP Data Integrity Guidance and FDA 21 CFR Part 11, 210 and 211. Oncologica was particularly reassured by Arkivums GDPR-compliant processes, as they frequently receive data access requests from patients.

Guy Yaniv, CEO, Arkivum, concludes: Life science organisations are fast becoming big data enterprises. In a climate of intense regulatory scrutiny and growing need to understand, share and collaborate with data, were thrilled to help Oncologica achieve this and deliver value. Through collaboration with Thermo Fisher, weve jointly delivered a pre-integrated solution for NGS data, releasing responsibility for data preservation and safeguarding at scale.

Arkivum
Rebecca Hicks
Head of Marketing
01249405060